Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / COLL - Collegium Pharmaceutical: Oversold And Cheap


COLL - Collegium Pharmaceutical: Oversold And Cheap

  • Shares of pain management drug concern Collegium Pharmaceutical have fallen over 40% as the biotech selloff, negative attitudes towards opiates, and patent cliffs have taken a toll.
  • The company's recent purchase of BioDelivery Sciences provides it with complementary suite of assets, an entry into neurology, and $75 million of cost synergies.
  • With high leverage expected to deflate by YE22 and currently trading at three times FY22E EPS, Collegium merited a deeper dive.
  • A full analysis follows in the paragraphs below.

For further details see:

Collegium Pharmaceutical: Oversold And Cheap
Stock Information

Company Name: Collegium Pharmaceutical Inc.
Stock Symbol: COLL
Market: NASDAQ
Website: collegiumpharma.com

Menu

COLL COLL Quote COLL Short COLL News COLL Articles COLL Message Board
Get COLL Alerts

News, Short Squeeze, Breakout and More Instantly...